Bevacizumab Intravenous and Dihydroergotamine Mesylate
Determining the interaction of Bevacizumab Intravenous and Dihydroergotamine Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Intravenous-Dihydroergotamine nasal
- Bevacizumab Intravenous-Dihydroergotamine Nasal Spray
- Bevacizumab Intravenous-Dilacor XR
- Bevacizumab Intravenous-Dilantin
- Bevacizumab Intravenous-Dilantin Infatabs
- Bevacizumab Intravenous-Dilantin injection
- Dihydroergotamine Mesylate-Bevacizumab-awwb
- Dihydroergotamine Mesylate-Bevacizumab-awwb Intravenous
- Dihydroergotamine Mesylate-Bevespi Aerosphere
- Dihydroergotamine Mesylate-Bevyxxa
- Dihydroergotamine Mesylate-Bexarotene
- Dihydroergotamine Mesylate-Bexarotene (Systemic)